Here, we present a novel approach for the chemical synthesis of chondroitin and dermatan sulfate oligosaccharides. A key point of this strategy is the preparation and use of an N-trifluoroacetyl galactosamine building block containing a 4,6-O-di-tertbutylsilylene group. Glycosylation reactions proceeded in good yields (74-91%) with our protecting group distribution. Using this approach, we have synthesized, for the first time, a chondroitin/dermatan sulfate-like tetrasaccharide that contains both types of uronic acids, D-glucuronic and L-iduronic acid. Moreover, we have employed a fluorescence polarization competition assay to evaluate the interactions between the synthesized oligosaccharides and FGF-2 (basic Fibroblast Growth Factor). Our results show that this method, using standard instrumentation and minimal sample consumption, is a powerful tool for the rapid analysis of the glycosaminoglycan affinity for proteins in solution.
Introduction
Chondroitin sulfate (CS) and dermatan sulfate (DS) are highly heterogeneous and sulfated, linear polysaccharides that belong to the glycosaminoglycan (GAG) family. 1, 2 CS is formed by the repetition of disaccharide units of D-glucuronic acid (GlcA) and Nacetyl-D-galactosamine (GalNAc), following the sequence GlcA-β(1→3)-GalNAcβ(1→4). The disaccharide repeating unit of the structurally related DS mainly contains L-iduronic acid (IdoA) in place of GlcA. Both polysaccharides may contain sulfate groups at different positions of the chain (Figure 1 ). These sulfate groups are introduced during the biosynthesis of these polymers, through the action of specific sulfotransferases, giving rise to GAG chains with a high level of structural diversity.
The microheterogeneity of CS and DS can be considered as a capacity to encode information and control a wide variety of biological processes by specific interactions with certain proteins. 3 As in the case of others members of the GAG family, such as heparin and heparan sulfate, [4] [5] [6] [7] [8] it is proposed that defined CS and DS oligosaccharide sequences are responsible for specific protein recognition and subsequent activity. 3 However, little is known about the exact structural requirements for these interactions.
In this context, synthetic CS and DS oligosaccharides [9] [10] [11] [12] [13] are useful tools for the establishment of structure-activity relationships and the preparation of mimetics that potentially modulate the biological functions of the natural products. [14] [15] [16] Interestingly, CS and DS are often found as co-polymeric structures. 17 These hybrid CS/DS chains, containing both types of uronic acids, GlcA and IdoA, are involved in growth factor signalling and neuronal growth and development. 17 The interaction between CS/DS and several chemokines and growth factors, including FGF-2 (basic Fibroblast Growth Factor), is mediated by oversulfated oligosaccharide sequences containing GlcA/IdoA-GalNAc (4,6-OSO3). [18] [19] [20] [21] In order to study these interactions at the molecular level, it would be very useful the access to well-defined synthetic CS/DS oligosaccharides. However, to the best of our knowledge, the synthesis of a CS/DS oligomer, containing both GlcA and IdoA, has not yet been reported.
Despite significant advances in the field, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] the synthesis of GAG oligosaccharides, including DS and CS, is still challenging, mainly due to the low reactivity of the building blocks required. [34] [35] [36] [37] There is still a great demand for efficient synthetic strategies, involving a robust and reliable set of carbohydrate building blocks. This is an important point for the successful automation of oligosaccharide synthesis. 33, [38] [39] [40] Here, we present a novel approach for the synthesis of CS and DS oligomers that is based on the use of an N-trifluroacetyl-protected galactosamine building block.
Glycosylation reactions proceeded in high yields using our design of protecting groups.
The efficiency of this strategy is illustrated with the total synthesis of the oversulfated tetrasaccharide 1 (Scheme 1) that contains both IdoA and GlcA and bears sulfate groups at positions 4 and 6 of the GalNAc units, position 2 of the uronic acid moieties, and position 4 of the non-reducing terminus. All these positions may be sulfated in the natural products (Figure 1 ), except position 4 of the non-reducing end. Interestingly, the introduction of a "non-natural" sulfate group at the reducing end did not significantly affect the FGF-2 affinity of a synthetic heparin hexasaccharide 41 and an "artificial" IdoA monosaccharide, sulfated at positions 2 and 4, showed considerable binding to several proteins. 42, 43 Moreover, we have developed a fluorescence polarization assay to analyse the binding of tetrasaccharide 1 and its di-O-benzylated precursor to a model heparin-binding protein, FGF-2. Fluorescence polarization measurements allowed the study of GAG oligosaccharide-protein interactions in solution, with minimal time and sample consumption, and using a standard fluorescence reader. Therefore, our results indicate that this method can be considered as a powerful tool to evaluate the binding affinities of synthetic oligosaccharides for receptors of biological relevance, helping to establish structure-activity relationships.
Results and discussion

Synthesis of chondroitin/dermatan sulfate-like oligosaccharides
For the synthesis of the CS/DS-related tetrasaccharide 1, we first prepared the required monosaccharide building blocks 2-4 (Scheme 1). Glucuronic acid trichloroacetimidate 2 was prepared from known diol 5, 44 as shown in Scheme 2. Selective oxidation at position 6 was performed by treatment of the diol 5 with calcium hypochlorite and catalytic TEMPO, under phase-transfer conditions. 44 Strict control of the reaction time and temperature, and quenching with Na2SO3 were required to avoid the chlorination of the electron-rich 4-methoxyphenyl ring. 45 The carboxylate intermediate was then esterified with BnBr and Bu4NI in DMF at 60ºC to give the benzyl uronate 6.
Levulinoylation at position 4, followed by oxidative removal of the 4-methoxyphenyl group with CAN, and trichloroacetimidate formation, afforded glycosyl donor 2.
Starting from diol 9, 46, 47 iduronic acid trichloroacetimidate 3 was obtained by levulinoylation, selective desilylation and anomeric activation with Cl3CCN and K2CO3.
Regarding the galactosamine unit, two types of building blocks, possessing different protections on the amino group, have been employed, up to date, for the synthesis of CS and DS oligosaccharides. 10 2-Azido-2-deoxy-galactose derivatives 11, 12, [48] [49] [50] [51] present some limitations for their general use due to the non-participating character of the azido moiety. On the contrary, 2-deoxy-2-trichloroacetamido-galactose building blocks lead to the stereoselective formation of the required 1,2-trans glycosidic bond. Impressive synthesis of CS oligomers have been reported using N-trichloroacetyl(TCA)-protected units. 3, 32, [52] [53] [54] [55] However, this amino protecting group is associated with some problems.
For example, we 56 and others 57 have detected the formation of stable trichlorooxazoline side products during glycosidation of 2-deoxy-2-trichloroacetamido donors. Moreover, several difficulties are occasionally encountered in the final transformation to the desired 2-acetamido group. Thus, the deprotection of multiple N-TCA groups by basic hydrolysis, followed by selective N-acetylation, requires very long reaction times. 57 Alternatively, radical reduction using tributylstannane afford, in some cases, significant amounts of mono-and dichloroacetamide intermediates. 58, 59 For these reasons, we considered the use of an alternative amine-protecting group for the synthesis of CS/DS oligosaccharides. We chose an N-trifluoroacetyl (TFA) group because it can be easily removed under mild conditions while ensures high β selectivities in glycosylation reactions. 60 Thus, we first planned the preparation of a N-TFA-protected galactosamine unit that should act as an efficient glycosyl acceptor in coupling reactions with uronic acid donors. The synthesis of such a compound was challenging (Scheme 3). Known tetraacetate 12 61, 62 was synthesized from galactosamine hydrochloride in 66% yield by treatment with NaOMe and then with trifluoroacetic anhydride and Et3N in MeOH, followed by extensive acetylation (Ac2O, Py, DMAP). Compound 12 was transformed into 4-methoxyphenyl glycoside 15 by glycosylation with 4-methoxyphenol, followed by de-O-acetylation and benzylidenation. This compound was an ideal candidate for our synthetic approach because the 4,6-O-benzylidene acetal would allow the selective sulfation of these positions at the end of the synthesis to generate, among others, biologically relevant type E sulfation sequences. 3 However, 15 suffered from poor solubility in organic solvents such as dichloromethane, toluene and acetonitrile, and glycosylation attempts with uronic acid donor 2 63 in THF or THF/CH2Cl2 mixtures did not give any desired disaccharide. We then decided to prepare compound 17 with a silyl ether group at the anomeric position. Selective cleavage of the anomeric acetyl group of 12 was followed by treatment with TDSCl to afford derivative 16. Acetate hydrolysis and benzylidenation gave compound 17. Surprisingly, this derivative proved to be unstable during silica gel chromatography. Therefore, 17 was not considered anymore as building block for our synthetic scheme. We then directed our attention to the 6-Ochloroacetylated building block 18, efficiently synthetized from 16 in two steps. It was anticipated that diol 18 would be selectively glycosylated at position 3. Unfortunately, glycosylation reactions between diol 18 and uronic acid donor 2 63 proceeded in low yield (<15%) and regioselectivity. Finally, we decided to prepare monosaccharide 4 containing a di-tert-butylsilylene group. It has been reported that this protecting group, compared to benzylidene acetals, confers desirable properties to glycosyl acceptors, such as better solubility in most organic solvents and higher stability under acidic glycosylation conditions. 58, 64 Thus, we treated monosaccharide 14 with di-tertbutylsilyl bistriflate in pyridine to obtain 4 in high yield. Gratifyingly, coupling of 4 with glucuronic acid trichloroacetimidate 2 gave the desired β (1→3) disaccharide 19 in excellent yield (Scheme 4). These results highlight the profound effect that protecting group distribution of the building blocks has on glycosylation reactions. 65 We also perfomed the glycosylation reaction between 4 and iduronic acid donor 3. The target α (1→3) disaccharide 20 was also obtained in high yield. The small-to-zero coupling constants for IdoA protons indicated that this residue mainly exists in 1 C4 conformation, and the value of the 1 JC, H (172 Hz) confirmed the α configuration of the new glycosidic linkage. 66 Next, we studied the 2+2 assembly of the disaccharide units 19 and 20 to generate a tetrasaccharide sequence containing both GlcA and IdoA. The 4,6-di-tert-butylsilylene group 67 of galactose and galactosamine donors leads to the selective formation of α glycosides despite the presence of participating groups at position 2. 68 In some cases, even 4,6-O-benzylidene derivatives of galactosamine donors may lead to loss of stereocontrol in coupling reactions with glucuronic acid-derived acceptors. 69 For these reasons, we decided to transform disaccharide 20 in a suitable protected donor containing less sterically hindered acetyl groups at positions 4 and 6 to obtain the , which proved to be soluble in water. This compound was converted into the corresponding calcium salt for NMR characterization because the 1 H-NMR spectrum of the sodium salt showed considerable signal overlap. NMR spectra showed the characteristic downfield shifts of the proton and carbon signals at positions bearing a sulfate group (see Table 1 and 2). COSY, HSQC and TOCSY NMR experiments were employed for the structural assignment. Additionally, mass spectroscopic analysis confirmed the structure of 30. Finally, hydrogenolysis of 30 gave the fully deprotected tetrasaccharide 1 in good yield. The structure of 1 was confirmed by NMR and mass spectroscopic analysis. The values of 1 H and 13 C NMR chemical shifts for sulfated positions are in good agreement with those reported in the literature for similar GAG sulfated sequences. 41, 53 
Fluorescence polarization measurements
Fluorescent polarization is a powerful tool for the study of biomolecular interactions in solution. 71 It is based on the observation that when a fluorescent molecule is excited with plane-polarized light, the remaining polarization of the emitted light depends on the rotational rate of the fluorescent molecule in solution that is inversely related to its molecular weight. Thus, the light emitted by a small fluorescent compound, which rotates quickly in solution, is highly depolarized and, therefore, the polarization value is low. If the fluorescent probe binds to a high molecular weight molecule, for example, a protein, the large complex rotates slower in solution, the emitted light remains polarized, and the polarization value is higher. Importantly, fluorescence polarization measurements do not require immobilization of protein or ligand to a surface for the analysis of the interaction. Thus, ligand's bound/free ratio can be directly measured in solution, avoiding potential misleading effects derived from the attachment of the biomolecules to solid supports. Moreover, this technique is adequate for high throughput screening, requires very little amount of samples, and is well suited for the binding analysis of small ligands, such as oligosaccharides, to a protein receptor.
Despite these advantages, fluorescence polarization has had a limited use in the study of carbohydrate-protein interactions, 72, 73 in part due to the lack of sensitive and appropiate instrumentation until the late 90's. Interestingly, competition assays can be easily designed to study the binding affinities of nonfluorescent ligands. 72 In fact, we employed a competition experiment to evaluate the affinity of synthetic tetrasaccharides 1 and 30 to FGF-2, as described below.
First, we prepared five different fluorescein-conjugated glycosaminoglycan oligosaccharides (36) (37) (38) (39) (40) to select an optimal probe for binding studies with FGF-2 (Scheme 7 and Supplementary information). Commercially available oligosaccharides 31-35, derived from natural heparin by enzymatic depolimerization, were functionalized by reaction of the aldehyde group of the reducing end of the chain with a hydrazidecontaining fluorescein molecule. 74 The corresponding glycosyl hydrazides were obtained in good yield, after purification by reverse phase C-18 chromatography. Then, fluorescent labelled sugars 36-40 were mixed with a fixed concentration of FGF-2, and polarization was measured in 384-well microplates using a standard fluorescence microplate reader ( Figure 2 ). Control wells containing only the fluorescent probe, without any protein, were included in the experiment. As expected, 75, 76 heparin hexasaccharide 38 and tetrasaccharide 37 bound to FGF-2 since a significant increased polarization value was observed in FGF-2 containing wells. No interaction was detected for heparin disaccharide 36 and hyaluronic acid oligosaccharides 39 and 40, ruling out any binding of FGF-2 to the fluorescein tag. Hexa 38, which gave best binding, was chosen as optimal probe for inhibition experiments (see below). Importantly, the use of 384-well plates allowed the minimization of the sample quantities required for these experiments: the standard assay was performed with 10 nM fluorescent probe and approximately 100 nM protein in a final volume of 40 µL per well.
Next, the binding of 38 to FGF-2 was measured with increasing concentrations of protein (see Supplementary information, Figure S1 ), giving the corresponding binding curve that was analyzed as a Langmuir isotherm to determine the dissociation constant (KD). The obtained value (117 ± 10 nM) was consistent with a previous measurement, in solution, of the binding affinity between a similar heparin hexasaccharide and FGF-2. 75 A competition binding assay was then optimized to analyze the binding affinites of nonfluorescent ligands, such as tetrasaccharides 1 and 30, to FGF-2. Thus, the polarization of samples containing fixed concentrations of protein and fluorescent probe were recorded in the presence of a certain concentration of potential competitors ( Figure 3 ).
In these experiments, we chose an FGF-2 concentration close to the KD of the interaction with 38 in order to get a high enough polarization value while still using the minimal amount of inhibitor. Besides 1 and 30, synthetic oligosaccharides 41-46 41, 77 were included in the screening ( Interestingly, the presence of 25 µM of 1 and 30 gave 63-67 % inhibition. A similar effect was observed with tetrasaccharide 43. These results indicated that CS/DS-related tetrasaccharides 1 and 30 are able to interact with FGF-2 and that their relative inhibitory potencies are similar to the one displayed by a heparin tetrasaccharide. After demonstrating that this fluorescence polarization assay can be used for the rapid screening of a library of compounds, we studied the inhibitory potency of oversulfated 1 in more detail. We measured the polarization of samples containing FGF-2, fluorescent 38 and increasing concentrations of tetrasaccharide 1 ( Figure 5 ). The obtained curve was fitted to the equation for a simple one-site competitive interaction. An IC50 value of 15 µM was estimated for compound 1. In terms of screening for inhibitors, our fluorescence polarization competition assay is advantageous over methods that require the immobilization of the ligand or the protein on a solid support and are based on the inhibition of the interaction that occurs at the surface, because this surface interaction can be affected by multivalency, involves unknown amounts of one of the biomolecules and requires additional washing and incubation steps.
The binding of FGF-2 to cell surface heparan sulfate GAGs is essential for tumor angiogenesis and growth. Inhibition of angiogenesis is a well established and important anti-cancer strategy and, therefore, there is a great interest on compounds that potentially inhibit the FGF-2/GAG interaction. 78 Our data indicate that CS/DS tetrasaccharides 1 and 30 display considerable inhibitory activity and can be considered as starting points for the design and synthesis of more active compounds. Moreover, recent studies 78, 79 indicate that the introduction of lipophilic groups on the structure of synthetic antiangiogenic molecules improved the properties of these anticancer agents, and, in this context, the activity showed by the di-O-benzylated 30 is particularly remarkable.
Conclusions
We have prepared a N-TFA-protected galactosamine unit as key building block for the synthesis of CS and DS oligosaccharides. While the participating N-TFA group ensures the desired 1,2-trans stereochemistry of the glycosidic bond, the temporary introduction of a di-tert-butylsilylene group at positions 4 and 6 transforms this moiety in an excellent glycosyl acceptor for coupling reactions with uronic acid donors. Our results provide an additional illustration of the profound impact that protecting groups have on the success of a glycosylation reaction. Moreover, our protecting group design is compatible with the deprotection/sulfation steps required for the preparation of final CS and DS sequences. Following this strategy, oversulfated CS/DS-like tetrasaccharide 1 was successfully synthesized. Importantly, our approach can be easily applied to the synthesis of other CS and DS oligosaccharides, bearing different sulfate patterns.
On the other hand, we have developed a fluorescence polarization assay for the rapid screening of the interactions between the synthesized oligosaccharides and proteins. The binding is analysed in solution, avoiding the potential artefacts and the additional washing steps that are typically associated to assays where the receptor or the ligand is The residue was purified by column chromatography (toluene/acetone 5:2) to afford 23 Occasionally, we found loss of FGF-2 activity when working with low concentrated aliquots in PBS buffer. For this reason, all measurements were alternatively done in PBS + 0.5% BSA (data not shown), getting similar results than those obtained with PBS. 
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